Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-20), Olba DVx Healthcare's 3-1 Month Momentum % is -5.71%.
The industry rank for Olba DVx Healthcare's 3-1 Month Momentum % or its related term are showing as below:
TSE:2689's 3-1 Month Momentum % is ranked worse than 75.4% of 126
companies
in the Medical Distribution industry
Industry Median: 2.315
vs TSE:2689: -5.71
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Olba DVx Healthcare 3-1 Month Momentum % Related Terms
TSE:2689 vs MCK, COR, CAH: 3-1 Month Momentum % Comparison
For the Medical Distribution subindustry, Olba DVx Healthcare's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Olba DVx Healthcare 3-1 Month Momentum % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Olba DVx Healthcare's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Olba DVx Healthcare's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Olba DVx Healthcare (TSE:2689) has a 3-1 Month Momentum % of -5.71% as of Sep. 20, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Olba DVx Healthcare and its competitors. According to the industry distribution chart, Olba DVx Healthcare ranks #95 out of 126 companies in the Medical Distribution industry, placing it in the top 75.4%.
Is Olba DVx Healthcare's 3-1 Month Momentum % too high?
Olba DVx Healthcare's current 3-1 Month Momentum % is -5.71%. Based on the distribution chart, Olba DVx Healthcare ranks #95 out of 126 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Olba DVx Healthcare has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olba DVx Healthcare's 3-1 Month Momentum % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Olba DVx Healthcare ranks #95 out of 126 companies for 3-1 Month Momentum %. This places Olba DVx Healthcare in the lower half of its industry. The industry median 3-1 Month Momentum % is 2.32. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Distribution company?
The median 3-1 Month Momentum % among Medical Distribution companies is 2.32, based on 126 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Olba DVx Healthcare and its competitors. For the Medical Distribution industry, the median 3-1 Month Momentum % is 2.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Olba DVx Healthcare's current 3-1 Month Momentum % is -5.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba DVx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Olba DVx Healthcare (TSE:2689) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,164.82, compared to a current price of 円1,925.00 — trading 11.1% below its estimated fair value. The current 3-1 Month Momentum % is -5.71%. Olba DVx Healthcare's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Olba DVx Healthcare (TSE:2689), the current 3-1 Month Momentum % is -5.71% as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olba DVx Healthcare (TSE:2689) Overvalued in 2026?
Based on GuruFocus' analysis, Olba DVx Healthcare stock appears to be undervalued.
The current stock price of 円1,925.00 is trading 11.1% below its estimated GF Value™ of 円2,164.82.
GuruFocus considers Olba DVx Healthcare to be Modestly Undervalued.
Key valuation signals for TSE:2689:
3-1 Month Momentum %: -5.71%
GF Value™: 円2,164.82 vs. price of 円1,925.00 (11.1% below fair value)
No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
62GF Score
Get the complete analysis for TSE:2689
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2689 has been successfully added to your 
